US Patent Issued to Johnson & Johnson Enterprise Innovation on April 21 for "Machine learning to predict lung cancer involvement of lymph nodes" (American, British Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,608,805, issued on April 21, was assigned to Johnson & Johnson Enterprise Innovation Inc. (New Brunswick, N.J.).

"Machine learning to predict lung cancer involvement of lymph nodes" was invented by George R. Washko Jr. (West Roxbury, Mass.), Raul San Jose Estepar (Wellesley, Mass.), Charles Matthew Kinsey (New Brunswick, N.J.) and Christopher Scott Stevenson (West Sussex, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods for determining a subject level risk of metastatic cancer involving the training and/or deployment of models to determine 1) a lymph node level risk of individual lymph node involvement and/or 2)...